GEP19991870B - Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists - Google Patents

Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists

Info

Publication number
GEP19991870B
GEP19991870B GEAP19964087A GEAP1996004087A GEP19991870B GE P19991870 B GEP19991870 B GE P19991870B GE AP19964087 A GEAP19964087 A GE AP19964087A GE AP1996004087 A GEAP1996004087 A GE AP1996004087A GE P19991870 B GEP19991870 B GE P19991870B
Authority
GE
Georgia
Prior art keywords
diones
receptor antagonists
alkyl amine
glutamate receptor
amine derivatives
Prior art date
Application number
GEAP19964087A
Other languages
English (en)
Inventor
Michael Francis Rafferty
Brian Edward Kornberg
Sham Nikam
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of GEP19991870B publication Critical patent/GEP19991870B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/34Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/10Formation of amino groups in compounds containing carboxyl groups with simultaneously increasing the number of carbon atoms in the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C07C255/22Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton containing cyano groups and at least two carboxyl groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GEAP19964087A 1995-06-07 1996-05-13 Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists GEP19991870B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/474,874 US5637767A (en) 1995-06-07 1995-06-07 Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid

Publications (1)

Publication Number Publication Date
GEP19991870B true GEP19991870B (en) 1999-12-06

Family

ID=23885291

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19964087A GEP19991870B (en) 1995-06-07 1996-05-13 Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists

Country Status (18)

Country Link
US (4) US5637767A (enExample)
EP (1) EP0830338B1 (enExample)
JP (1) JP3874306B2 (enExample)
AT (1) ATE210628T1 (enExample)
CA (1) CA2219150C (enExample)
CZ (2) CZ296895B6 (enExample)
DE (1) DE69617948T2 (enExample)
DK (1) DK0830338T3 (enExample)
EE (1) EE04053B1 (enExample)
ES (1) ES2170231T3 (enExample)
GE (1) GEP19991870B (enExample)
HU (2) HU228194B1 (enExample)
NZ (2) NZ308319A (enExample)
PL (3) PL185560B1 (enExample)
PT (1) PT830338E (enExample)
SI (1) SI0830338T1 (enExample)
SK (2) SK283507B6 (enExample)
WO (1) WO1996040617A1 (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858736A (en) * 1996-05-17 1999-01-12 E. I. Du Pont De Nemours And Company Preparation of lactams from aliphatic α,ω-dinitriles
AU714980B2 (en) 1996-07-24 2000-01-13 Warner-Lambert Company Llc Isobutylgaba and its derivatives for the treatment of pain
AU9019198A (en) 1997-08-19 1999-03-08 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
KR100694735B1 (ko) * 1999-06-10 2007-03-14 워너-램버트 캄파니 엘엘씨 일치환 및 이치환된 3-프로필 감마-아미노부티르산
US6891059B2 (en) * 2000-01-27 2005-05-10 Warner-Lambert Company Asymmetric synthesis of pregabalin
GB2368579A (en) * 2000-10-31 2002-05-08 Parke Davis & Co Ltd Azole pharmaceutical agents
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
KR100823758B1 (ko) * 2004-03-12 2008-04-21 워너-램버트 캄파니 엘엘씨 C1-대칭 비스포스핀 리간드 및 프레가발린의 비대칭합성에서의 이들의 용도
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CN102102114B (zh) * 2004-06-21 2013-08-14 沃尼尔·朗伯有限责任公司 普瑞巴林和相关化合物的制备
US7417165B2 (en) * 2005-04-06 2008-08-26 Teva Pharmaceutical Industries Ltd. Crystalline forms of pregabalin
EP1768950A2 (en) * 2005-04-11 2007-04-04 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
JP2008505980A (ja) * 2005-05-10 2008-02-28 テバ ファーマシューティカル インダストリーズ リミティド イソブチルグルタル酸を有さないプレガバリン及びその調製方法
ATE486841T1 (de) * 2005-05-10 2010-11-15 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
WO2006121557A1 (en) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
EP1879854B1 (en) * 2005-05-10 2011-09-07 Teva Pharmaceutical Industries Ltd Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
US7563923B2 (en) * 2005-09-19 2009-07-21 Teva Pharmaceutical Industries Ltd. Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the synthesis of (S)-Pregabalin
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
CA2646474A1 (en) * 2006-04-24 2007-11-08 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 3-isobutylglutaric acid
WO2007139933A2 (en) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
KR20080036060A (ko) * 2006-05-31 2008-04-24 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린의 중간체의 제조에 효소 분할을 이용하는 방법
US20080015385A1 (en) * 2006-05-31 2008-01-17 Lilach Hedvati Preparation of (S)-pregabalin-nitrile
US20090286880A1 (en) * 2006-07-12 2009-11-19 Generics [Uk] Limited Novel process
WO2008062460A2 (en) * 2006-10-06 2008-05-29 Cadila Healthcare Limited Crystalline forms of pregabalin
KR101036536B1 (ko) * 2007-03-22 2011-05-24 테바 파마슈티컬 인더스트리즈 리미티드 (s)-(+)-3-(아미노메틸)-5-메틸 헥산산의 합성
WO2008138874A1 (en) * 2007-05-09 2008-11-20 Chemo Ibérica, S.A. Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
EP1992609A1 (en) * 2007-05-14 2008-11-19 Dipharma Francis S.r.l. A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid
WO2009001372A2 (en) * 2007-06-25 2008-12-31 Manne Satyanarayana Reddy A novel process for the preparation of pregabalin
WO2009044409A2 (en) * 2007-10-01 2009-04-09 Natco Pharma Limited Novel resolution process for pregabalin
US20090137842A1 (en) * 2007-10-03 2009-05-28 Vollerner Yuri Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
ITMI20072262A1 (it) * 2007-12-03 2009-06-04 Dipharma Francis Srl Procedimento per la preparazione di acido (s)(+)-3-(amminometil)-5-metilesanoico
EP2225199A2 (en) * 2007-12-18 2010-09-08 Watson Pharma Private Limited Improved process for the preparation of (s)-pregabalin
JP2011507941A (ja) * 2007-12-26 2011-03-10 ジェネリクス・(ユーケー)・リミテッド プレガバリンの製造方法
US7879903B2 (en) 2007-12-27 2011-02-01 Toray Fine Chemicals Co., Ltd. Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine
WO2009082861A1 (en) * 2008-01-02 2009-07-09 Zhejiang Jiuzhou Pharmaceutical Co., Ltd. New resolution process of (s)-3-aminomethyl-5-methylhexanoic acid
US20110144383A1 (en) * 2008-02-18 2011-06-16 Matrix Laboratories Limited Process for preparing (s)-3-(aminomethyl)-5-methylhexanoic acid
AU2009233536A1 (en) * 2008-04-04 2009-10-08 Generics [Uk] Limited Novel process
EP2110372A1 (en) 2008-04-16 2009-10-21 Chemo Ibérica, S.A. Intermediates for the preparation of Pregabalin and process for their preparation
CN101585778B (zh) * 2008-05-19 2014-08-13 上海臣邦医药科技有限公司 一种普瑞巴林制备方法
CN102099482B (zh) * 2008-05-21 2014-04-16 桑多斯股份公司 5-甲基-3-硝基甲基-己酸酯的立体选择性酶水解方法
CN102112436A (zh) * 2008-06-03 2011-06-29 基因里克斯(英国)有限公司 用于合成氨基酸的新的和有效方法
WO2009158343A1 (en) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
WO2010061403A2 (en) * 2008-11-26 2010-06-03 Ind-Swift Laboratories Limited Process to prepare highly pure (s)-pregabalin
WO2010070593A2 (en) 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Malonate esters
IT1394292B1 (it) 2009-05-07 2012-06-06 Dipharma Francis Srl Procedimento per la sintesi di pregabalina
ES2362913B1 (es) 2009-12-24 2012-05-24 Moehs Iberica S.L. Nuevo método para la preparación de (s)-pregabalina.
HUP1000186A2 (en) 2010-04-08 2011-10-28 Richter Gedeon Nyrt Novel industrial process of preparing (s)-(+) pregabalin
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
US8212072B2 (en) 2010-08-13 2012-07-03 Divi's Laboratories, Ltd. Process for the preparation of pregabalin
WO2012025861A1 (en) 2010-08-23 2012-03-01 Pfizer Manufacturing Ireland Process for the preparation of ( s ) - 3 - cyano - 5 - methylhexanoic acid derivatives adn of pregabalin
US8895769B2 (en) 2011-04-20 2014-11-25 Kemphys Ltd. Silicon-containing carboxylic acid derivative
EP2527319A1 (en) 2011-05-24 2012-11-28 Laboratorios Del. Dr. Esteve, S.A. Crystalline forms of pregabalin and co-formers in the treatment of pain
WO2014061714A1 (ja) 2012-10-18 2014-04-24 公益財団法人乙卯研究所 ケイ素含有カルボン酸誘導体
CA2888877C (en) 2012-11-07 2021-07-27 Hikal Limited A process for the preparation of pregabalin
CN103980144B (zh) * 2014-05-16 2018-08-17 浙江华海药业股份有限公司 一种普瑞巴林中间体母液的套用方法
US9745249B2 (en) 2014-06-12 2017-08-29 Siegfried Ltd. Method for the preparation of beta-substituted gamma-amino carboxylic acids
CN104086439B (zh) * 2014-06-30 2018-11-16 浙江华海药业股份有限公司 一种pregabalin中间体拆分剂(R)-(+)-α-苯乙胺的回收方法
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
CN104649919B (zh) * 2015-02-10 2021-02-12 浙江华海药业股份有限公司 一种小颗粒普瑞巴林的制备方法
MA44212A (fr) 2015-05-26 2018-12-26 Isa Odidi Prégabaline à libération prolongée contrôlée
CN105175276A (zh) * 2015-07-25 2015-12-23 安徽东凯生物科技有限公司 一种光学纯(r)-3-氨甲酰甲基-5-甲基己酸的合成方法
CN105085290A (zh) * 2015-08-18 2015-11-25 太仓运通生物化工有限公司 一种合成普瑞巴林的方法
CN105061234A (zh) * 2015-08-18 2015-11-18 太仓运通生物化工有限公司 一种制备普瑞巴林的方法
CN105348125A (zh) * 2015-11-26 2016-02-24 太仓运通生物化工有限公司 一种以异戊醛为原料合成普瑞巴林的方法
CN111333529A (zh) * 2018-12-19 2020-06-26 北京万全德众医药生物技术有限公司 普瑞巴林的一种制备方法
CN109942446B (zh) * 2019-04-17 2021-09-07 黄冈鲁班药业股份有限公司 一种普瑞巴林的制备方法
JP7720911B2 (ja) 2020-12-04 2025-08-08 ラボラトリオス シラネス、エセ.ア.デ セ.べ. 痛みに対するオピオイド鎮痛薬と抗てんかん薬のコーティングされた安定な固体医薬組成物
CN112939809A (zh) * 2020-12-30 2021-06-11 江苏恒沛药物科技有限公司 一种1-氰基-3-甲基丁基丙二酸二乙酯的制备方法
CN116041214B (zh) * 2022-11-15 2025-04-22 奥锐特药业股份有限公司 一种普瑞巴林中间体的制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2516307A (en) * 1949-01-06 1950-07-25 Gen Mills Inc Vinyl resins plasticized with cyano esters
US3110723A (en) * 1959-08-18 1963-11-12 Rohm & Haas Process for preparing monochlorinated cyanoesters
US3133954A (en) * 1959-08-18 1964-05-19 Rohm & Haas Process for preparing chlorinated cyanoesters
US3444161A (en) * 1965-09-02 1969-05-13 Shionogi Seiyaku Kk Alkyl cyano aluminum compounds and process for introducing a cyano group into an alpha,beta unsaturated carbonyl compound
DE1793347A1 (de) * 1968-09-04 1972-02-03 Dynamit Nobel Ag Verfahren zur Herstellung von substituierten Cyanbuttersaeuren
JPS54100316A (en) * 1978-01-25 1979-08-08 Meiji Seika Kaisha Ltd Preparation of derivative of aminobutyric acid
US4428887A (en) * 1982-07-14 1984-01-31 Monsanto Company Method of producing mono-substituted terminal diesters
DE3227388A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von (alpha)-substituierten ss-dicarbonyl-, ss-cyancarbonyl- und ss-dicyanverbindungen
US4760089A (en) * 1985-09-09 1988-07-26 Smithkline Beckman Corporation Irreversible dopamine-β-hydroxylase inhibitors
US5132451A (en) * 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5077425A (en) * 1990-04-02 1991-12-31 E. I. Du Pont De Nemours And Company Nitrile-accelerated hydrocarboxylation
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
AU677008B2 (en) * 1992-05-20 1997-04-10 Northwestern University Gaba and L-glutamic acid analogs for antiseizure treatment

Also Published As

Publication number Publication date
US20010016665A1 (en) 2001-08-23
HU0500934D0 (en) 2005-12-28
PL185425B1 (pl) 2003-05-30
AU700091B2 (en) 1998-12-24
ATE210628T1 (de) 2001-12-15
HU228194B1 (en) 2013-01-28
CA2219150A1 (en) 1996-12-19
NZ501628A (en) 2001-09-28
DE69617948D1 (de) 2002-01-24
JPH11506726A (ja) 1999-06-15
SK283507B6 (sk) 2003-08-05
HU229957B1 (hu) 2015-03-30
EE04053B1 (et) 2003-06-16
JP3874306B2 (ja) 2007-01-31
HUP9802504A2 (hu) 1999-02-01
SK282865B6 (sk) 2003-01-09
MX9708652A (es) 1998-06-30
PL185560B1 (pl) 2003-06-30
PL185557B1 (pl) 2003-06-30
CZ384697A3 (cs) 1998-03-18
DE69617948T2 (de) 2002-06-13
CZ296895B6 (cs) 2006-07-12
CA2219150C (en) 2008-11-18
EP0830338B1 (en) 2001-12-12
US5840956A (en) 1998-11-24
WO1996040617A1 (en) 1996-12-19
CZ291147B6 (cs) 2002-12-11
EE9700320A (et) 1998-06-15
US5637767A (en) 1997-06-10
PT830338E (pt) 2002-04-29
SK164597A3 (en) 1998-05-06
DK0830338T3 (da) 2002-04-02
NZ308319A (en) 2000-02-28
PL323795A1 (en) 1998-04-27
ES2170231T3 (es) 2002-08-01
HUP9802504A3 (en) 2000-06-28
SI0830338T1 (en) 2002-04-30
US6046353A (en) 2000-04-04
EP0830338A1 (en) 1998-03-25
AU5792196A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
GEP19991870B (en) Alkyl Amine Derivatives of Substituted Quinoxaline 2,3-Diones as Glutamate Receptor Antagonists
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
CA2242425A1 (en) Quinazoline derivatives as vegf inhibitors
CA2263319A1 (en) Quinazoline derivatives and pharmaceutical compositions containing them
EP0638567A4 (en) ADENOSINE INHIBITORS.
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
DK336589D0 (da) Benzodiazepinderivater
WO2000046199A3 (en) Indole derivatives as anti-inflammation agents
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
PL315035A1 (en) Cyclic amide derivatives as antagonistic substances in respect to neurokinin a
CA2360360A1 (en) Piperidyl benzamide compounds, composition containing same and their use thereof
NZ331060A (en) Quinoxalinediones, preparation and pharmaceutical compositions thereof
KR870700067A (ko) 피리도(2,3-d)-피리미딘 유도체
FI860878A0 (fi) Aminosyraderivat och foerfarande foer deras framstaellning.
IL91704A0 (en) Imidazoline derivatives,their preparation and pharmaceutical compositions containing them
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
GEP20012389B (en) Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia
GEP19991869B (en) Amino Acid Derivatives of Substituted Quinoxaline 2,3-Dione Derivatives as Glutamate Receptor Antagonists
YU51498A (en) 2,4-diaminopyrimidine derivatives
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
NO172893C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive cefem-forbindelser
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
EP0654032A1 (en) Quinuclidine derivatives as squalene synthase inhibitors.
NO950177D0 (no) Farmakologisk aktive erivater